Novoray Corp. (688300)
SSE
Closed
Sep 18, 2026
Day's Range
168.5052 wk Range
52.75Overview - 688300 - Novoray Corp.
Key Statistics
Valuation
Enterprise Value
42.66B
P/E (Trailing)
‪141.47‬
P/E (Forward)
‪71.02‬
PEG Ratio
‪71.02‬
Price / Sales (TTM)
‪34.84‬
Price / Book
‪23.90‬
EV / EBITDA
‪109.38‬
Profitability
Gross Margin
‪36.31%‬
Profit Margin
‪24.72%‬
Operating Margin
‪24.30%‬
Return on Assets
‪8.30%‬
Return on Equity
‪18.15%‬
Ownership
Shares Outstanding
241.46M
Float
86.69M
Held by Insiders
‪64.39%‬
Held by Institutions
‪10.63%‬
Price stats
Beta
‪1.34‬
50-Day Avg
‪154.25‬
200-Day Avg
‪115.00‬
Dividends
Payout Ratio
‪40.00%‬
Frequency
Annual
Analyst Consensus
2 analysts
Average price target
‪CN¥ 151.00‬Market Cap - 688300 - Novoray Corp.
Peers - 688300 - Novoray Corp.
Peer Comparison
Compared with companies in Specialty Chemicals listed on SSE.
Profile Summary - 688300 - Novoray Corp.
About
Novoray Corp. is a company specializing in the development and manufacturing of diagnostic imaging technology. It primarily focuses on designing advanced imaging solutions that cater to the medical sector. The company's range of products includes cutting-edge MRI machines and CT scanners, which are integral tools in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
